How to buy scPharmaceuticals stock

scPharmaceuticals Inc is a biotechnology business based in the US. scPharmaceuticals shares (SCPH) are listed on the NASDAQ and all prices are listed in US Dollars. scPharmaceuticals employs 27 staff and has a market cap (total outstanding shares value) of 0.00.

scPharmaceuticals share price

Use our graph to track the performance of SCPH stocks over time.

scPharmaceuticals shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$5.21 - $11.99
50-day moving average	$6.85
200-day moving average	$7.28
Wall St. target price	$12.33
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.45

Buy scPharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy scPharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of scPharmaceuticals Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

scPharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	-20.08%
Return on equity TTM	-48.24%
Profit margin	0%
Book value	$3.01
Market capitalisation	$183.6 million

TTM: trailing 12 months

Shorting scPharmaceuticals shares

There are currently 325,561 scPharmaceuticals shares held short by investors – that's known as scPharmaceuticals's "short interest". This figure is 0.5% up from 324,044 last month.

There are a few different ways that this level of interest in shorting scPharmaceuticals shares can be evaluated.

scPharmaceuticals's "short interest ratio" (SIR)

scPharmaceuticals's "short interest ratio" (SIR) is the quantity of scPharmaceuticals shares currently shorted divided by the average quantity of scPharmaceuticals shares traded daily (recently around 94365.507246377). scPharmaceuticals's SIR currently stands at 3.45. In other words for every 100,000 scPharmaceuticals shares traded daily on the market, roughly 3450 shares are currently held short.

However scPharmaceuticals's short interest can also be evaluated against the total number of scPharmaceuticals shares, or, against the total number of tradable scPharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case scPharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 scPharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.0219% of the tradable shares (for every 100,000 tradable scPharmaceuticals shares, roughly 22 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against scPharmaceuticals.

Find out more about how you can short scPharmaceuticals stock.

scPharmaceuticals share dividends

We're not expecting scPharmaceuticals to pay a dividend over the next 12 months.

scPharmaceuticals share price volatility

Over the last 12 months, scPharmaceuticals's shares have ranged in value from as little as $5.21 up to $11.99. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while scPharmaceuticals's is 0.3784. This would suggest that scPharmaceuticals's shares are less volatile than average (for this exchange).

scPharmaceuticals overview

scPharmaceuticals Inc. , a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. scPharmaceuticals Inc.

Frequently asked questions

What percentage of scPharmaceuticals is owned by insiders or institutions?
Currently 8.497% of scPharmaceuticals shares are held by insiders and 65.595% by institutions. How many people work for scPharmaceuticals?
Latest data suggests 27 work at scPharmaceuticals. When does the fiscal year end for scPharmaceuticals?
scPharmaceuticals's fiscal year ends in December. Where is scPharmaceuticals based?
scPharmaceuticals's address is: 2400 District Avenue, Burlington, MA, United States, 01803 What is scPharmaceuticals's ISIN number?
scPharmaceuticals's international securities identification number is: US8106481059 What is scPharmaceuticals's CUSIP number?
scPharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 810648105